This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.
Increased use of nested and ready-to-use primary packaging has resulted in a need for more validation data on container-closure integrity. This article describes efforts to develop these data for new and traditional containers and closures.
Method-transfer kits help simplify analytical method transfer for global site certifications.
The year 2011 may seem far off, but there is much to do to prepare for electronic pedigrees.
This article focuses on drawing parallels between ICH Q14/Q2(R2), United States Pharmacopeia (USP) <1220>, and International Organization for Standardization/International Electrotechnical Commission (ISO/IEC) 17025:2017.
The authors describe a new method for the production of personalised medicines utilising ultra-precise microdrop printing technology.
The development of CAR-T therapies for solid tumor cancers presents a myriad of challenges.
Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.
Webinar Date/Time: Wed, Jun 12, 2024 11:00 AM EDT
QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.
Using one system for test execution and sample management, improving right-first-time, and allowing review by exception can deliver access to key lab data faster.
Both biosimilar and generic drugs have an abbreviated approval process; however, the clinical trial requirements differ enormously.
Analytical methods need a boost to ensure quality control for cell and gene therapies.
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
Ray Guidotti, Chief Operating Officer at Simtra BioPharma Solutions, talks about the company's strategic development and how it supports customers with a focus on excellence.
Analytical procedure performance can be continually verified by risk-based monitoring of performance related data.
This paper reflects upon the past 15 years of experience in the application of QRM and KM within the pharmaceutical GMP environment.
We have proposed a comprehensive capping index parameter which is a ratio of compact anisotropic index to material anisotropic index. This study will help to design or select right tooling for successful tablet manufacturing.
The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
In order to combat the threat of counterfeits in Europe, the EU's current anti-counterfeiting directive is being amended.
Eradicating paper-based workflows and standalone solutions operating in isolation provides a good starting point to update quality management processes.
This tutorial paper is meant to aid in dielectric-sensor selection
While companies today outsource numerous processes, from early development through to manufacturing, there are still many opportunities to realize the full potential of outsourcing services.
The authors describe the background and applications of fully formulated aqueous shellac for film-coating systems.
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
Several steps need be taken to achieve lights-out, fully automated operations.
In this first of a four-part series, the authors provide an introduction to a practical approach for establishing specification equivalence. The regulatory basis and compliance examples from FDA observations and warning letters are included to support the need for an effective process.